Spero Therapeutics, Inc. Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit
Spero Therapeutics, Inc. (SPRO) reported Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit of $5.90 per share for the 1-month period ending 2017-07-31, per its 10-Q filed 2017-12-14.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit · last filed 2020-03-16
- 2017-07-31: Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit 0 month $5.90; Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit 1 month $5.90.
| Period end | Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit 0 month | Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit 1 month |
|---|---|---|
| 2017-07-31 | $5.90 10-K · filed 2020-03-16 | $5.90 10-Q · filed 2017-12-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 |